Steven Cohen acquired 1.47 Million Recursion Pharmaceuticals shares worth $11.9 Million. That's 0.04% of their equity portfolio (490th largest holding). The stake costed the investor $10.9 Million, netting the investor a gain of 9.8% so far.
Avg closing price
Price range
Increased shares by 969.2% (+1.33 Million shares)
Q4 2023